IP Library Granted Patent US 8,632,987
Granted Patent B2
US 8,632,987 · App. 13/670,293 · Granted Jan 21, 2014

Methods and compositions for treating and diagnosing diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,632,987
App. No.
13/670,293
Granted
Jan 21, 2014
Kind
B2
Abstract

Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.

Claims (5)

1. A method of diagnosing brain cancer in a human, the method comprising detecting the level of Na—K ATPase beta3 protein in a sample from the human, and diagnosing said human as having brain cancer when the level is elevated relative to a control Na—K ATPase beta3 protein level established for a non-cancerous sample.

2. The method of claim 1 , wherein the amino acid sequence of the Na—K ATPase beta3 protein comprises a sequence selected from the group consisting of SEQ ID NOS:127-134.

3. The method of claim 1 , wherein the amino acid sequence of the Na—K ATPase beta3 protein consists of a sequence selected from the group consisting of SEQ ID NOS:127-134.

4. The method of claim 1 , wherein the level of Na—K ATPase beta3 protein is detected by contacting the sample from the human with an isolated antibody that selectively binds to the Na—K ATPase beta3 protein and detecting binding of the antibody to the Na—K ATPase beta3 protein.

5. The method of claim 4 , wherein the antibody is coupled to a detectable substance.